Pureland Group
Overview
Pureland Group is a private investment group and family office that started in 2014. It operates two main portfolios: one focused on capital preservation in secondary markets, and another, Pureland Global Venture (PGV), which is an impact-driven venture capital fund investing globally in medical technology. The venture arm focuses on early-stage companies in sectors like HealthTech, Life Sciences, and High Tech, with a mission to improve medical access, particularly in emerging markets.
Portfolio Companies
3
Website
purelandgroup.coInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Leo Cancer Care | Jul 2021 | Series B | Lead |
| AMILI | Jun 2022 | Series A | Co-investor |
| One Health Group | Oct 2024 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Pureland Group based?
Pureland Group is headquartered in Singapore, Central Singapore, Singapore.
When was Pureland Group founded?
Founding year information for Pureland Group is not publicly available.
How many portfolio companies does Pureland Group have?
Pureland Group has 3 portfolio companies in Caplight's dataset.
What are some companies in Pureland Group's portfolio?
Portfolio companies visible on Caplight include Leo Cancer Care, AMILI, One Health Group.
What was Pureland Group's most recent investment shown here?
Pureland Group's most recent investment in this portfolio sample was in One Health Group in 2024.
What sectors does Pureland Group focus on?
Pureland Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Pureland Group focus on?
Pureland Group typically invests at the Early stage.